Trump Links Tylenol To Autism In Unproven Claim Amid Public Backlash

President Donald Trump, accompanied by Health Secretary Robert F. Kennedy Jr., publicly linked acetaminophen (Tylenol) use during pregnancy to an increased risk of autism, urging pregnant women to avoid the drug and calling for FDA label updates. The administration also promoted leucovorin as a potential treatment for some autism symptoms, describing the findings as a major medical breakthrough. However, medical experts criticized the claims, highlighting that the evidence is inconclusive and largely based on older or inconsistent studies, with caution urged against equating correlation with causation. The announcements triggered significant public backlash, including from parents and advocates of autistic children, who expressed frustration and concern over the misleading information and potential harm from discouraging necessary medication during pregnancy. The controversy unfolded alongside other news, such as the return of Jimmy Kimmel's late-night show following a brief suspension. These developments underscore ongoing debates about autism's causes and treatments amid political and social tensions.